WASHINGTON, D.C. — Benchmark Litigation again named Wilkinson Stekloff the “Boutique Firm of the Year” during its annual awards ceremony in New York City — the second time in three years that Wilkinson Stekloff has received the recognition.
This prestigious award recognizes Wilkinson Stekloff’s high-profile trial wins over the last year, including a defense verdict for the National Collegiate Athletic Association (NCAA) in McNair v. NCAA and multiple state-court bellwether trial victories for Bayer in trials involving the blood-thinner Xarelto. Wilkinson Stekloff also achieved several other pre- and post-trial victories in 2018, including judgment granted as a matter of law to Wilkinson Stekloff’s clients Oculus and Facebook on plaintiffs’ false designation claim in Zenimax Media et al. v. Oculus VR and complete dismissal, before any discovery, of a securities fraud class action case in In re MAXIMUS, Inc. Securities Litig.
“We are deeply appreciative of Benchmark’s recognition of our firm for the second time in three years, which only further underscores how effective and talented Wilkinson Stekloff’s trial teams are,” said founding partner Alexandra Walsh. “I couldn’t be prouder of our team and their tireless efforts to get only the best results for our clients.”
Wilkinson Stekloff is entering its fourth year after winning a series of high-profile victories, led by a large and diverse group of partners, all of whom participated in trials and case-dispositive hearings in 2018. More information about Wilkinson Stekloff’s banner year in 2018, including pre- and post-trial victories, staff hires, and award recognitions, can be found here.
The Benchmark Litigation guide identifies the leading U.S. trial attorneys and firms at the local and national levels. Focused on the litigation market in North America, the publication’s rankings and editorials are the results of an extensive research process that includes detailed interviews with private practice lawyers and in-house counsel.
###